- Home
- DD vs HLN Comparison
DD vs HLN Comparison
Compare DD & HLN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- DD
- HLN
- Stock Information
- Founded
- DD 2015
- HLN 2022
- Country
- DD United States
- HLN United Kingdom
- Employees
- DD N/A
- HLN N/A
- Industry
- DD Major Chemicals
- HLN Package Goods/Cosmetics
- Sector
- DD Industrials
- HLN Consumer Discretionary
- Exchange
- DD Nasdaq
- HLN Nasdaq
- Market Cap
- DD 34.8B
- HLN 41.1B
- IPO Year
- DD N/A
- HLN N/A
- Fundamental
- Price
- DD $78.46
- HLN $9.24
- Analyst Decision
- DD Buy
- HLN Strong Buy
- Analyst Count
- DD 12
- HLN 2
- Target Price
- DD $96.91
- HLN $10.48
- AVG Volume (30 Days)
- DD 2.2M
- HLN 9.1M
- Earning Date
- DD 02-11-2025
- HLN 02-27-2025
- Dividend Yield
- DD 1.94%
- HLN 1.70%
- EPS Growth
- DD N/A
- HLN N/A
- EPS
- DD 1.88
- HLN 0.18
- Revenue
- DD $12,192,000,000.00
- HLN $15,065,004,686.00
- Revenue This Year
- DD $5.63
- HLN $2.44
- Revenue Next Year
- DD $5.10
- HLN $2.43
- P/E Ratio
- DD $41.50
- HLN $25.68
- Revenue Growth
- DD N/A
- HLN N/A
- 52 Week Low
- DD $61.14
- HLN $7.89
- 52 Week High
- DD $90.06
- HLN $10.80
- Technical
- Relative Strength Index (RSI)
- DD 55.23
- HLN 39.27
- Support Level
- DD $75.08
- HLN $8.86
- Resistance Level
- DD $76.77
- HLN $9.32
- Average True Range (ATR)
- DD 1.29
- HLN 0.12
- MACD
- DD 0.58
- HLN -0.02
- Stochastic Oscillator
- DD 95.89
- HLN 50.00
About DD DuPont de Nemours Inc.
DuPont is a diversified global specialty chemicals company created in 2019 as a result of the DowDuPont merger and subsequent separations. Its portfolio includes specialty chemicals and downstream products that serve the electronics, water, construction, safety and protection, automotive, and healthcare industries. DuPont plans to separate the company into three companies going forward, one focused on electronics, one focused on water, and one with more diversified end market exposure. We expect the separations will occur by mid-2026.
About HLN Haleon plc (Each representing two)
Haleon is one of the largest consumer health companies in the world. Formed by a combination of consumer health divisions of GSK, Pfizer, and Novartis, Haleon separated from GSK and went public in July 2022. The firm generates 60% of sales from global power brands including Sensodyne, Advil, Centrum, and Poligrip, that play in many geographies and are often leaders in their respective categories. It also has a number of local brands, including Emergen-C, Eno, Tums, and Caltrate, that are more tailored to regional needs and have strong local brand equity. Overall, Haleon's brands tackle a variety of silos within consumer health including oral care, digestive health, pain relief, and nutrition.